Piezo Motion has introduced a new micro-dosing pump that can replace separate lab devices traditionally used for fluid handling applications.
Piezo Motion, a US-based provider of precision motor technology, has introduced a new piezoelectric micro-dosing pump, a first-of-its-kind technology that enables accurate fluid handling applications for scientists across life science laboratories. The company’s innovative design, launched in March 2021, eliminates the drivetrain of traditional pumps by replacing it with a drive mechanism that provides improved performance and responsiveness.
The design consists of a three-in-one microinjector that provides continuous microflow, rapid micro-dosing, microinjection, micro-suction, rapid sampling, and mixing. The footprint is compact at 3.5" by 4.5". In addition, applications that traditionally require two or three separate laboratory devices can now be replaced with this single piezoelectric micro-dosing pump, the company said in a March 17, 2021 press release.
The micro-dosing pump is capable of precise control over dispensed fluid volumes as small as a single nanoliter droplet size with ultra-smooth delivery. The system also includes a programmable user interface and pre-installed operating software. Both the pump and controller come complete and ready-to-use with stainless-steel foot mounts or optional retort stand attachments.
"At the heart of this micro-dosing pump is our ultra-precise rotary piezo motor. This isn't just a pump, it is a microinjector with unmatched responsiveness and control. Not only does our pump have a small footprint it can also replace multiple laboratory devices," said Hassan Kotob, chairman and CEO of Piezo Motion, in the press release.
Source: Piezo Motion
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.